Vagus Nerve Stimulation for Cerebral Palsy

This trial tests a new treatment for adults with cerebral palsy who experience ongoing musculoskeletal pain. It will determine if a device that stimulates the vagus nerve through the ear (transcutaneous auricular vagus nerve stimulation) can reduce pain and improve quality of life. Participants will receive either the actual nerve stimulation or a sham (fake) treatment for comparison. Individuals with cerebral palsy who have experienced chronic pain for at least a year and regularly endure moderate pain might be suitable candidates. The trial aims to assess the safety and effectiveness of this treatment in managing pain. As an unphased trial, this study provides a unique opportunity to contribute to pioneering research that could lead to innovative pain management solutions.

The trial does not specify if you need to stop your current medications, but it requires that your pain and/or anti-inflammatory medication dosing has been stable for at least 6 weeks before joining.

Research has shown that transcutaneous auricular vagus nerve stimulation (taVNS), which gently stimulates a nerve in the ear, is generally well-tolerated. In past studies, participants did not discontinue treatment due to discomfort. Only two minor side effects were reported, and these did not lead anyone to stop the treatment. Another study found that taVNS is safe and may be effective when combined with other therapies. So far, taVNS appears to be a promising and safe option for those interested in using it for cerebral palsy and pain management.¹²³⁴⁵

Researchers are excited about transcutaneous auricular vagus nerve stimulation (taVNS) for cerebral palsy because it offers a non-invasive way to potentially improve motor function by stimulating the vagus nerve through the ear. Current treatments for cerebral palsy often include physical therapy, medication for muscle relaxation, and sometimes surgery, but taVNS represents a novel approach by directly targeting neural pathways. Unlike these traditional methods, taVNS uses a specific delivery method that targets the cymba conchae of the left ear, which is thought to activate the vagus nerve more effectively. This innovative mechanism could lead to enhanced outcomes with fewer side effects and pave the way for new therapeutic strategies in managing cerebral palsy.

Research has shown that transcutaneous auricular vagus nerve stimulation (taVNS) might benefit people with cerebral palsy. In this trial, participants will receive either active taVNS or a sham version. Studies have found that taVNS can improve movement and sensation, which are often impaired by cerebral palsy. Early evidence also suggests it can help reduce muscle and joint pain, a common issue for those with this condition. Additionally, taVNS has been linked to better emotional well-being and quality of life. While more research is needed, these findings suggest taVNS could effectively manage cerebral palsy symptoms.²³⁴⁶⁷